Skip to main content
Elsevier
View Cart

Books in Pharmacology

Elsevier's Pharmacology collection studies how drugs interact with biological systems to improve health and treat disease. It covers pharmacodynamics, exploring drug effects on biology, and pharmacokinetics, studying how the body affects drugs. Branches like Pharmacogenetics. Essential for pharmacologists, this collection offers invaluable insights into drug interactions, efficacy, and safety, crucial for advancing drug development and improving patient outcomes.

BooksJournals

    • Biomarkers and Biosensors

      • 1st Edition
      • December 8, 2014
      • Ajit Sadana + 1 more
      • English
      • Hardback
        9 7 8 0 4 4 4 5 3 7 9 4 2
      • Paperback
        9 7 8 0 4 4 4 6 3 8 3 8 0
      • eBook
        9 7 8 0 4 4 4 5 3 7 9 5 9
      Biomarkers and Biosensors offers thorough coverage of biomarker/biosensor interaction, current research trends, and future developments in applications of drug discovery. This book is useful to researchers in this field as well as clinicians interested in new developments in early detection and diagnosis of disease or the mode of operation of biomarkers. Biomarkers and Biosensors also emphasizes kinetics, and clearly delineates how this influences the biomarker market.

    • Personalized Cancer Chemotherapy

      • 1st Edition
      • December 5, 2014
      • Da Yong Lu
      • English
      • Hardback
        9 7 8 0 0 8 1 0 0 3 4 6 6
      • Paperback
        9 7 8 0 0 8 1 0 1 6 2 2 0
      • eBook
        9 7 8 0 0 8 1 0 0 3 4 7 3
      Personalized Cancer Chemotherapy separately describes and addresses "individualized cancer chemotherapy" (ICC) strategies new and old, to provide readers with new insights into their characteristics and techniques, as well as key debates and future trends in this area. The book devotes chapters to drug sensitivity testing, cancer biomarkers and bioinformatics detection, pharmacogenetics, individualized antimetastatic therapy, drug combinations, assistant chemotherapy, and cost-effectiveness considerations. A major obstacle to controlling cancer growth and metastases in patients is the inappropriate use of anticancer and antimetastatic drugs. Researchers and clinicians are now beginning to focus on ICC also called "personalized cancer chemotherapy" (PCC), to improve therapeutic quality and outcomes by selecting and prescribing the most appropriate and effective drugs. Using genetic, molecular, and bioinformatics data and modern experimental techniques, known tumor genes can be detected more easily than ever before; the average speed of genetic sequencing has increased 15,000 to 50,000 times since the Human Geonme Project was completed. This book will help readers understand the pros and cons of each individualized cancer chemotherapy strategy from different angles so as to make good judgments and predictions of drug responses and clinical outcomes.

    • Side Effects of Drugs Annual

      • 1st Edition
      • Volume 36
      • December 1, 2014
      • English
      • Hardback
        9 7 8 0 4 4 4 6 3 4 0 7 8
      • eBook
        9 7 8 0 4 4 4 6 3 3 9 1 0
      The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.

    • Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders

      • 1st Edition
      • Volume 71
      • September 19, 2014
      • English
      • Hardback
        9 7 8 0 1 2 8 0 0 2 8 2 7
      • eBook
        9 7 8 0 1 2 8 0 0 3 3 8 1
      This new volume of Advances in Pharmacology presents pharmacology of the blood brain barrier, focusing on targeting CNS disorders. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.

    • Drugs During Pregnancy and Lactation

      • 3rd Edition
      • September 17, 2014
      • Christof Schaefer + 2 more
      • English
      • Hardback
        9 7 8 0 1 2 4 0 8 0 7 8 2
      • eBook
        9 7 8 0 1 2 4 0 7 9 0 1 4
      Drugs During Pregnancy and Lactation, Third Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each chapter contains twofold information regarding drugs that are appropriate for prescription during pregnancy and an assessment of the risk of a drug when exposure during pregnancy has already occurred. Thoroughly updated with current regulations, references to the latest pharmacological data, and new medicinal products, this edition is a comprehensive resource covering latest knowledge and findings related to drugs during lactation and pregnancy.

    • Chesley's Hypertensive Disorders in Pregnancy

      • 4th Edition
      • August 28, 2014
      • Robert N. Taylor + 3 more
      • English
      • Hardback
        9 7 8 0 1 2 4 0 7 8 6 6 6
      • Paperback
        9 7 8 0 1 2 8 1 0 0 6 4 6
      • eBook
        9 7 8 0 1 2 4 0 7 9 4 5 8
      Chesley’s Hypertensive Disorders in Pregnancy continues its tradition as one of the beacons to guide the field of preeclampsia research, recognized for its uniqueness and utility. Hypertensive disorders remain one the major causes of maternal and fetal morbidity and death. It is also a leading cause of preterm birth now known to be a risk factor in remote cardiovascular disease. Despite this the hypertensive disorders remain marginally studied and management is often controversial.The fourth edition of Chesley’s Hypertensive Disorders in Pregnancy focuses on prediction, prevention, and management for clinicians, and is an essential reference text for clinical and basic investigators alike. Differing from other texts devoted to preeclampsia, it covers the whole gamut of high blood pressure, and not just preeclampsia.

    • Proteomics in Biomedicine and Pharmacology

      • 1st Edition
      • Volume 95
      • June 24, 2014
      • English
      • Hardback
        9 7 8 0 1 2 8 0 0 4 5 3 1
      • eBook
        9 7 8 0 1 2 8 0 0 5 9 5 8
      Volume 95 of Advances in Protein Chemistry and Structural Biology focuses on advances in proteomic techniques and their application in biomedicine and pharmacology. This volume describes in detail the applications of these techniques in studying a number of diseases and specific protein modifications and profiles, including phosphoproteomics, glycoproteomics, and more. Published continuously since 1944, the Advances in Protein Chemistry and Structural Biology series is the essential resource for protein chemists. Each volume brings forth new information about protocols and analysis of proteins. Each thematically organized volume is guest edited by leading experts in a broad range of protein-related topics.

    • Integrative Cardiovascular Chinese Medicine

      • 1st Edition
      • June 11, 2014
      • Anika Niambi Al-Shura
      • English
      • Paperback
        9 7 8 0 1 2 8 1 0 3 4 1 8
      • Hardback
        9 7 8 0 1 2 4 2 0 0 1 4 2
      • eBook
        9 7 8 0 1 2 4 2 0 0 7 7 7
      Combining the research and study of integrative Chinese and Western Medicine, Integrative Cardiovascular Chinese Medicine: A Prevention and Personalized Medicine Perspective presents a clear, structured base to guide clinical practice and encourage collaboration between Chinese medicine and Western medicine practitioners. This complete reference work thoroughly covers the pathophysiology of cardiology-related diseases, and compares, juxtaposes, and integrates Western and traditional Chinese medicine (TCM). Anika Niambi Al-Shura provides a realistic scope of cardiology treatment and the integration of Western and Chinese medicine, establishing a basis for standardization and a rationale for the inclusion of TCM in cardiology, and identifying and inspiring ideas for future research.

    • Pharmacology and Therapeutics of Constitutively Active Receptors

      • 1st Edition
      • Volume 70
      • June 11, 2014
      • Ya-Xiong Tao
      • English
      • Hardback
        9 7 8 0 1 2 4 1 7 1 9 7 8
      • eBook
        9 7 8 0 1 2 4 1 7 2 0 6 7
      Volume 70 of Advances in Pharmacology presents the pharmacology and therapeutics of constitutively active receptors. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists, and biochemists alike. Advances in Pharmacology provides a rich collection of reviews on timely topics. The series places emphasis on the molecular bases of drug action, both applied and experimental.

    • Biased Signaling in Physiology, Pharmacology and Therapeutics

      • 1st Edition
      • June 5, 2014
      • Brian J Arey
      • English
      • Paperback
        9 7 8 0 1 2 8 1 0 3 1 0 4
      • Hardback
        9 7 8 0 1 2 4 1 1 4 6 0 9
      • eBook
        9 7 8 0 1 2 4 1 1 5 0 7 1
      Biased Signaling in Physiology, Pharmacology and Therapeutics is a unique and essential reference for the scientific community concerning how conformational-depen... activation is a common phenomenon across many classes of receptors or signaling molecules. It discusses the role of conformational dynamics in leading to signaling bias across different classes of receptors and signaling molecules. By providing a broader view of signaling bias, this resource helps to explain common mechanisms shared across receptor classes and how this can be utilized to elucidate their cellular activity and better understand their therapeutic potential. Written for both new and established scientists in pharmacology, cell biology, biochemistry, and signal transduction, as well as physicians, this book clearly illustrates how biased receptor signaling can be utilized to develop and understand complex pharmacology. Chapters are each focused on a specific class of receptor or other important topic and make use of real-world examples illustrating how the latest research in signal transduction has led to a better understanding of pharmacology and cell biology. This structure creates a basis for understanding that physiological signalling bias has been selected by nature in order to provide complex and tissue- specific biological responses in the face of limited receptors and signaling pathways. This book provides a framework to reveal that these physiological mechanisms are not restricted to one receptor type or family and thus presents receptor signaling from a newer, more global perspective.

Related subjects

Biochemical pharmacology

Cardiovascular pharmacology

Clinical pharmacology therapeutics

Clinical trials

Drug adverse reactions and interactions

Endocrine exocrine pharmacology

Ethnopharmacology

Gastrointestinal pharmacology

Immunopharmacology pharmacology

Molecular pharmacology

Neoplastic cancer pharmacology

Pharmacokinetics pharmacodynamics

Pharmacology general

Principles of pharmacology

Psychoneuropharmacology

Pulmonary pharmacology

Renal and electrolyte pharmacology